We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+2.97%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.72B
AUM Growth
-$344M
Cap. Flow
-$310M
Cap. Flow %
-18%
Top 10 Hldgs %
22.96%
Holding
279
New
14
Increased
72
Reduced
169
Closed
14

Sector Composition

Rank Sector Weight
1 Technology 27.05%
2 Healthcare 26.07%
3 Industrials 15.04%
4 Consumer Discretionary 11.17%
5 Communication Services 6.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LNTH icon
101
Lantheus
LNTH
$6.59B
$4.33M 0.25%
61,607
-25,156
-29% -$1.91M
RYTM icon
102
Rhythm Pharmaceuticals
RYTM
$7.9B
$4.17M 0.24%
170,357
+11,357
+7% +$211K
VICR icon
103
Vicor
VICR
$10.2B
$4.11M 0.24%
69,427
+7,270
+12% +$480K
STRL icon
104
Sterling Infrastructure
STRL
$16.8B
$4.07M 0.24%
189,596
+3,480
+2% +$83.6K
GFF icon
105
Griffon
GFF
$4.67B
$4.06M 0.24%
137,681
-1,944
-1% -$59.1K
POWI icon
106
Power Integrations
POWI
$3.52B
$3.95M 0.23%
61,448
-604
-1% -$45.2K
FNKO icon
107
Funko
FNKO
$354M
$3.88M 0.23%
192,010
+393
+0.2% +$9.01K
ADTN icon
108
Adtran
ADTN
$657M
$3.86M 0.22%
197,338
-46,576
-19% -$1.02M
BVS icon
109
Bioventus
BVS
$1.17B
$3.73M 0.22%
533,322
-1,774
-0.3% -$13.9K
CUTR
110
DELISTED
Cutera, Inc.
CUTR
$3.64M 0.21%
79,734
+157
+0.2% +$7.16K
FIVE icon
111
Five Below
FIVE
$13.3B
$3.56M 0.21%
25,852
+1,984
+8% +$261K
MTRN icon
112
Materion
MTRN
$5.94B
$3.55M 0.21%
44,394
-405
-0.9% -$33.4K
ZUO
113
DELISTED
Zuora, Inc.
ZUO
$3.55M 0.21%
+481,368
New +$4.15M
SMLR
114
DELISTED
Semler Scientific
SMLR
$3.54M 0.21%
+94,418
New +$3.56M
VIAV icon
115
Viavi Solutions
VIAV
$9.31B
$3.53M 0.2%
270,179
-2,381
-0.9% -$33.9K
ALNT icon
116
Allient
ALNT
$1.93B
$3.4M 0.2%
118,636
+307
+0.3% +$9.16K
ETSY icon
117
Etsy
ETSY
$7.68B
$3.35M 0.19%
33,437
-46,176
-58% -$4.71M
HSKA
118
DELISTED
Heska Corp
HSKA
$3.35M 0.19%
+45,887
New +$4.06M
EXPO icon
119
Exponent
EXPO
$3.2B
$3.34M 0.19%
38,090
+79
+0.2% +$7.49K
TTEK icon
120
Tetra Tech
TTEK
$9.04B
$3.34M 0.19%
129,910
-835
-0.6% -$23.4K
MNRO icon
121
Monro
MNRO
$380M
$3.33M 0.19%
76,576
-14,136
-16% -$669K
XPOF icon
122
Xponential Fitness
XPOF
$201M
$3.31M 0.19%
181,256
+377
+0.2% +$6.35K
NIC icon
123
Nicolet Bankshares
NIC
$3.62B
$3.26M 0.19%
46,328
-428
-0.9% -$33K
SLP icon
124
Simulations Plus
SLP
$371M
$3.26M 0.19%
67,093
+137
+0.2% +$8K
VPG icon
125
Vishay Precision Group
VPG
$912M
$3.24M 0.19%
109,497
+219
+0.2% +$6.97K

Similar funds

Rice Hall James & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Rice Hall James & Associates held 279 positions worth $1.72B, down 17% from $2.07B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Rice Hall James & Associates withdrew a net $310M in Q3 2022, closing 14 positions and reducing 169 holdings. Its most notable exit was Global Blood Therapeutics, Inc., an estimated $7.39M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in TechTarget worth $8.44M.

  • Rice Hall James & Associates's largest Q3 2022 buy was TechTarget: 142,597 shares worth $8.44M.
  • Rice Hall James & Associates added most to Upland Software in Q3 2022, an estimated $3.67M increase.
  • Rice Hall James & Associates's biggest Q3 2022 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $26.8M.
  • Rice Hall James & Associates fully exited Global Blood Therapeutics, Inc. in Q3 2022, selling an estimated $7.39M.
  • Rice Hall James & Associates's ten largest holdings make up 23% of its $1.72B portfolio in Q3 2022.
  • Rice Hall James & Associates opened 14 new positions and closed 14 in Q3 2022.
  • Rice Hall James & Associates's portfolio value fell 17% quarter-over-quarter to $1.72B.

Based on Rice Hall James & Associates's 13F filing for Q3 2022, filed 1 Nov 2022.